Granulocyte-macrophage colony-stimulating factor (CSF2), a hematopoietic growth factor governing myeloid lineage development from precursor cells50, exhibits strong associations with poor clinical outcomes in various cancer types (82). The gene discussed is CSF2; the disease is cancer.